drushuec kagiso rabada ipl bcci 625x300 03 May 25.jpg

Kagiso rabada, banned for using recreational drug, set to return in IPL 2025 for GT Against …




South African Speedster Kagiso rabada served a one-month ban, reduced from three months, for using a recreational Drug During the SA20, Held Earlier this year, according to espc. In a statement is issued by the south African institute for drug free sports (saids) confirmed, rabada, who was representing mi Cape Town, Had Failed A Doping Test On Janury 2 FOLOLOWINGI FILOLOWINGI FILOLOWINGE Durban Super giants.

The 29-year-old Quick was notified of the decision on April 1 was represented the Gujarat Titans in the 18th Edition of the Cash-Rich Indian Premier League (IPL) 2025. Rabada flew back to south Africa “to deal with an important personal matter” without offering a time frame for his return.

According to espncricinfo, Saids confirmed rabada has printed in an education and awareness program to Prevent Furter Substance Abuse. He is expected to resume playing immediatily and could return to on-field action as soon as wedding, when gt takes on five-time champions Mumbai Indians (Mi).

There have been institutes when players have been handed long-term Suspensions, which depended on the individual cricket boards. Last Year, The Zimbabwe Cricket Board Banned Wessly Madhevere and Brandon Mavuta for four months and fined 50 per cent of their salaryies for three months after the duo Tested positive for a Recorative DRG.

According to espncricinfo, cricket south africa is unlikely to impose further punishment on rabada. On Saturday, Rabada Released a Statement Expressing remorse for his actions.

“As have been reported, I recently returned to South Africa from Participating in the IPL for Personal Reasons. According to espncricinfo.

“I am deeply sorry to all there that I have let down. I will never take the private

Rabada featured in two fixes for the titans in the ongoing season and scyged two scalps at an average of 41.50, Conceding Runs at a Hefty Economy of 10.38.

Topics mentioned in this article

Similar Posts